Endocrinology & metabolism

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS21
Academic Journal
Presents an abstract of the research manuscript `PSA promoter induction of RNA in a cell-free in vitro transcription assay,' by R. Snoek, N.B. Bruchovsky et al from the British Columbia Cancer Agency. Prostate specific antigen (PSA); Ribonucleic acid; Prostate cancer cells.


Related Articles

  • The function of microRNAs, small but potent molecules, in human prostate cancer. Sevli, S.; Uzumcu, A.; Solak, M.; Ittmann, M.; Ozen, M. // Prostate Cancer & Prostatic Diseases;2010, Vol. 13 Issue 3, p208 

    Prostate cancer is one of the most significant cancers of men all over the world. The microRNAs (miRNAs) possess crucial functions in pathogenesis of the disease and its gain of androgen independency. The miRNAs are small, approximately 18–24 nucleotides, non-coding, endogenously...

  • Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Prensner, John R; Iyer, Matthew K; Balbin, O Alejandro; Dhanasekaran, Saravana M; Cao, Qi; Brenner, J Chad; Laxman, Bharathi; Asangani, Irfan A; Grasso, Catherine S; Kominsky, Hal D; Cao, Xuhong; Jing, Xiaojun; Wang, Xiaoju; Siddiqui, Javed; Wei, John T; Robinson, Daniel; Iyer, Hari K; Palanisamy, Nallasivam; Maher, Christopher A; Chinnaiyan, Arul M // Nature Biotechnology;Aug2011, Vol. 29 Issue 8, p742 

    Noncoding RNAs (ncRNAs) are emerging as key molecules in human cancer, with the potential to serve as novel markers of disease and to reveal uncharacterized aspects of tumor biology. Here we discover 121 unannotated prostate cancer-associated ncRNA transcripts (PCATs) by ab initio assembly of...

  • Corrected serum T level may improve PCa detection. Guttman, Cheryl // Urology Times;8/15/2005, Vol. 33 Issue 10, p38 

    Reports on the results of a retrospective analysis of men presenting for prostate biopsy that indicate that correcting prostate specific antigen (PSA) density based on testosterone level may improve specificity for cancer detection in men with elevated PSA, presented at the 2005 meeting of the...

  • Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy. Huang, C.-N.; Huang, S.-P.; Pao, J.-B.; Chang, T.-Y.; Lan, Y.-H.; Lu, T.-L.; Lee, H.-Z.; Juang, S.-H.; Wu, P.-P.; Pu, Y.-S.; Hsieh, C.-J.; Bao, B.-Y. // Annals of Oncology;Mar2012, Vol. 23 Issue 3, p707 

    Background: Activated androgen receptor binds to androgen-responsive elements (AREs) in genome to regulate target gene transcription and, consequently, mediates physiological or tumorigenic processes of the prostate. Our aim was to determine whether genetic variants in AREs are associated with...

  • FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A. Periyasamy, S.; Hinds, T.; Shemshedini, L.; Shou, W.; Sanchez, E. R. // Oncogene;3/18/2010, Vol. 29 Issue 11, p1691 

    Prostate cancer (PCa) growth is dependent on androgens and on the androgen receptor (AR), which acts by modulating gene transcription. Tetratricopeptide repeat (TPR) proteins (FKBP52, FKBP51 and Cyp40) interact with AR in PCa cells, suggesting roles in AR-mediated gene transcription and cell...

  • Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. Bainbridge, Matthew N; Warren, Rene L; Hirst, Martin; Romanuik, Tammy; Zeng, Thomas; Go, Anne; Delaney, Allen; Griffith, Malachi; Hickenbotham, Matthew; Magrini, Vincent; Mardis, Elaine R; Sadar, Marianne D; Siddiqui, Asim S; Marra, Marco A; Jones, Steven JM // BMC Genomics;2006, Vol. 7, p246 

    Background: High throughput sequencing-by-synthesis is an emerging technology that allows the rapid production of millions of bases of data. Although the sequence reads are short, they can readily be used for re-sequencing. By re-sequencing the mRNA products of a cell, one may rapidly discover...

  • p68/DdX5 Supports β-Catenin & RNAP II during Androgen Receptor Mediated Transcription in Prostate Cancer. Clark, Emma L.; Hadjimichael, Christiana; Temperley, Richard; Barnard, Amy; Fuller-Pace, Frances V.; Robson, Craig N. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    The DEAD box RNA helicase p68 (Ddx5) is an important androgen receptor (AR) transcriptional co-activator in prostate cancer (PCa) and is over-expressed in late stage disease. β-Catenin is a multifunctional protein with important structural and signalling functions which is up-regulated in PCa...

  • Selection of RNA aptamers specific to active prostate-specific antigen. Sujin Jeong; Seung Ryul Han; Young Ju Lee; Seong-Wook Lee // Biotechnology Letters;Mar2010, Vol. 32 Issue 3, p379 

    A counter-SELEX procedure with recombinant purified active prostate specific antigen (PSA) was used to identify specific RNA aptamers against the active PSA. We developed two different kinds of counter-SELEX methods; one includes pre-clearance step with inactive proPSA protein, and the other...

  • siRNA Knockdown of Ribosomal Protein Gene RPL19 Abrogates the Aggressive Phenotype of Human Prostate Cancer. Bee, Alix; Brewer, Daniel; Beesley, Carol; Dodson, Andrew; Forootan, Shiva; Dickinson, Timothy; Gerard, Patricia; Lane, Brian; Yao, Sheng; Cooper, Colin S.; Djamgoz, Mustafa B. A.; Gosden, Christine M.; Youqiang Ke; Foster, Christopher S. // PLoS ONE;2011, Vol. 6 Issue 7, p1 

    We provide novel functional data that posttranscriptional silencing of gene RPL19 using RNAi not only abrogates the malignant phenotype of PC-3M prostate cancer cells but is selective with respect to transcription and translation of other genes. Reducing RPL19 transcription modulates a subset of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics